Kolatkar A R, Leung A K, Isecke R, Brossmer R, Drickamer K, Weis W I
Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
J Biol Chem. 1998 Jul 31;273(31):19502-8. doi: 10.1074/jbc.273.31.19502.
The mammalian hepatic asialoglycoprotein receptor, a member of the C-type animal lectin family, displays preferential binding to N-acetylgalactosamine compared with galactose. The structural basis for selective binding to N-acetylgalactosamine has been investigated. Regions of the carbohydrate-recognition domain of the receptor believed to be important in preferential binding to N-acetylgalactosamine have been inserted into the homologous carbohydrate-recognition domain of a mannose-binding protein mutant that was previously altered to bind galactose. Introduction of a single histidine residue corresponding to residue 256 of the hepatic asialoglycoprotein receptor was found to cause a 14-fold increase in the relative affinity for N-acetylgalactosamine compared with galactose. The relative ability of various acyl derivatives of galactosamine to compete for binding to this modified carbohydrate-recognition domain suggest that it is a good model for the natural N-acetylgalactosamine binding site of the asialoglycoprotein receptor. Crystallographic analysis of this mutant carbohydrate-recognition domain in complex with N-acetylgalactosamine reveals a direct interaction between the inserted histidine residue and the methyl group of the N-acetyl substituent of the sugar. Evidence for the role of the side chain at position 208 of the receptor in positioning this key histidine residue was obtained from structural analysis and mutagenesis experiments. The corresponding serine residue in the modified carbohydrate-recognition domain of mannose-binding protein forms a hydrogen bond to the imidazole side chain. When this serine residue is changed to valine, loss in selectivity for N-acetylgalactosamine is observed. The structure of this mutant reveals that the beta-branched valine side chain interacts directly with the histidine side chain, resulting in an altered imidazole ring orientation.
哺乳动物肝脏去唾液酸糖蛋白受体是C型动物凝集素家族的成员,与半乳糖相比,它对N-乙酰半乳糖胺具有优先结合性。人们已经研究了其选择性结合N-乙酰半乳糖胺的结构基础。受体的碳水化合物识别结构域中被认为在优先结合N-乙酰半乳糖胺方面很重要的区域,已被插入到一个先前经过改造以结合半乳糖的甘露糖结合蛋白突变体的同源碳水化合物识别结构域中。结果发现,引入一个与肝脏去唾液酸糖蛋白受体第256位残基对应的组氨酸残基,会使与半乳糖相比对N-乙酰半乳糖胺的相对亲和力增加14倍。半乳糖胺的各种酰基衍生物竞争结合这个修饰后的碳水化合物识别结构域的相对能力表明,它是去唾液酸糖蛋白受体天然N-乙酰半乳糖胺结合位点的良好模型。这个与N-乙酰半乳糖胺结合的突变碳水化合物识别结构域的晶体学分析揭示了插入的组氨酸残基与糖的N-乙酰取代基的甲基之间的直接相互作用。从结构分析和诱变实验中获得了受体第208位侧链在定位这个关键组氨酸残基中的作用的证据。甘露糖结合蛋白修饰后的碳水化合物识别结构域中的相应丝氨酸残基与咪唑侧链形成氢键。当这个丝氨酸残基变为缬氨酸时,观察到对N-乙酰半乳糖胺的选择性丧失。这个突变体的结构表明,β-支链的缬氨酸侧链直接与组氨酸侧链相互作用,导致咪唑环方向改变。